A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer.

Liu, Xiaonan; Chen, Xinyuan; Chen, Deqi; Liu, Yuxiang; Quan, Hong; Gao, Linrui; Yan, Lingling; Dai, Jianrong et al. · Radiother Oncol · 2024

retrospective_cohort · Level III

Where this comes from

Abstract

Fast and automated generation of treatment plans is desirable for magnetic resonance imaging (MRI)-guided adaptive radiotherapy (MRIgART). This study proposed a novel patient-specific auto-planning method and validated its feasibility in improving the existing online planning workflow. Data from 40 patients with prostate cancer were collected retrospectively. A patient-specific auto-planning method was proposed to generate adaptive treatment plans. First, a population dose-prediction model (M<sub>0</sub>) was trained using data from previous patients. Second, a patient-specific model (M<sub>ps</sub>) was created for each new patient by fine-tuning M<sub>0</sub> with the patient's data. Finally, an auto plan was optimized using the parameters derived from the predicted dose distribution by M<sub>ps</sub>. The auto plans were compared with manual plans in terms of plan quality, efficiency, dosimetric verification, and clinical evaluation. The auto plans improved target coverage, reduced irradiation to the rectum, and provided comparable protection to other organs-at-risk. Target coverage for the planning target volume (+0.61 %, P = 0.023) and clinical target volume 4000 (+1.60 %, P < 0.001) increased. V<sub>2900cGy</sub> (-1.06 %, P = 0.004) and V<sub>1810cGy</sub> (-2.49 %, P < 0.001) to the rectal wall and V<sub>1810cGy</sub> (-2.82 %, P = 0.012) to the rectum were significantly reduced. The auto plans required less planning time (-3.92 min, P = 0.001), monitor units (-46.48, P = 0.003), and delivery time (-0.26 min, P = 0.004), and their gamma pass rates (3 %/2 mm) were higher (+0.47 %, P = 0.014). The proposed patient-specific auto-planning method demonstrated a robust level of automation and was able to generate high-quality treatment plans in less time for MRIgART in prostate cancer.

Medical subject headings